0001209191-23-038481.txt : 20230620 0001209191-23-038481.hdr.sgml : 20230620 20230620170401 ACCESSION NUMBER: 0001209191-23-038481 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230615 FILED AS OF DATE: 20230620 DATE AS OF CHANGE: 20230620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spaventa Andrew CENTRAL INDEX KEY: 0001859701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40443 FILM NUMBER: 231026129 MAIL ADDRESS: STREET 1: 10931 N. TORREY PINES ROAD, SUITE 100 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Singular Genomics Systems, Inc. CENTRAL INDEX KEY: 0001850906 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 812948451 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-7830 MAIL ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-15 0 0001850906 Singular Genomics Systems, Inc. OMIC 0001859701 Spaventa Andrew 3010 SCIENCE PARK ROAD SAN DIEGO CA 92121 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-06-15 4 M 0 14583 A 24349 D Common Stock 2023-06-15 4 G 0 14583 0.00 D 9766 D Common Stock 2023-06-15 4 G 0 14583 0.00 A 3928154 I By The Andrew K. Spaventa Living Trust dated April 9, 2014 Restricted Stock Units 2023-06-15 4 M 0 14583 D Common Stock 14583 218750 D Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Immediately upon vesting of the Reporting Person's RSUs, the Reporting Person transferred his shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in 16 equal quarterly installments measured from March 15, 2023. /s/ Dalen Meeter, Attorney-in-Fact 2023-06-20